Stock listing
Lang & Schwarz:A2QJRW BioInvent International AB Aktie
German listing (Lang & Schwarz) of BioInvent International AB · home listing Stockholm:BINV
Follow BioInvent International AB into a list and get an email when it puts out news.
Home listing price · OMXSTO:BINV
2.75 SEK -0.17 (-5.7%)
Close on Nov 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:BINV
- Day range
- 2.66 – 2.95 SEKNov 16, 2026
- Volume
- 215,209 sharesNov 16, 2026
- Market cap
- 181.0M SEKAt the close on Nov 16, 2026 · price × 65.80M shares outstanding
- 52-week range
- 1.90 – 34.75 SEKLowest and highest trades, Nov 17, 2025 – Nov 16, 2026
- Traded on an average day
- 2.94M SEKMedian day 87,167 shares · last 3 months, Aug 17, 2026 – Nov 16, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:BINV · Home | 2.75 SEK | -0.165 (-5.7%) | 215,209 | 2.91 | 2.945 | 2.66 | 2.915 | Close on Nov 16, 2026 |
| Frankfurt:BIX0 | €0.269 EUR | +0.003 (+1.1%) | — | €0.257 | €0.269 | €0.257 | €0.266 | Close on Nov 13, 2026 |
| OTC:BOVNF | $0.28 USD | 0.00 (0.0%) | — | $0.28 | $0.28 | $0.28 | $0.28 | Close on Nov 11, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 16, 2026 · OMXSTO:BINV · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 2.75 | -0.165 | -5.7% | 2.91 | 2.945 | 2.66 | 215,209 | |
| 2.915 | -0.005 | -0.2% | 2.915 | 3.02 | 2.705 | 215,441 | |
| 2.92 | -0.10 | -3.3% | 3.015 | 3.315 | 2.78 | 411,993 | |
| 3.02 | -0.04 | -1.3% | 3.07 | 3.07 | 2.855 | 388,596 | |
| 3.06 | +0.115 | +3.9% | 2.96 | 3.305 | 2.865 | 957,209 | |
| 2.945 | +0.455 | +18.3% | 2.635 | 3.14 | 2.215 | 2,200,022 | |
| 2.49 | -1.225 | -33.0% | 2.17 | 3.22 | 1.90 | 2,698,939 | |
| 3.715 | +0.13 | +3.6% | 3.585 | 3.88 | 3.50 | 466,864 | |
| 3.585 | -0.22 | -5.8% | 3.92 | 4.08 | 3.51 | 565,335 | |
| 3.805 | -0.495 | -11.5% | 4.00 | 4.10 | 3.60 | 1,841,077 | |
| 4.30 | -1.13 | -20.8% | 5.10 | 5.10 | 4.10 | 2,628,195 | |
| 5.43 | -0.28 | -4.9% | 5.85 | 6.19 | 5.24 | 1,513,922 | |
| 5.71 | -14.99 | -72.4% | 11.50 | 11.50 | 5.36 | 6,109,655 | |
| 20.70 | -0.10 | -0.5% | 20.70 | 21.90 | 20.45 | 151,421 | |
| 20.80 | +0.30 | +1.5% | 20.65 | 21.30 | 20.20 | 98,643 | |
| 20.50 | +0.25 | +1.2% | 20.50 | 21.15 | 18.40 | 279,537 | |
| 20.25 | -0.25 | -1.2% | 20.60 | 21.40 | 20.25 | 73,550 | |
| 20.50 | 0.00 | 0.0% | 21.20 | 21.20 | 20.50 | 71,982 | |
| 20.50 | -1.05 | -4.9% | 22.25 | 22.25 | 20.30 | 178,086 | |
| 21.55 | -0.05 | -0.2% | 21.60 | 21.90 | 20.95 | 64,014 | |
| 21.60 | -1.80 | -7.7% | 23.40 | 23.55 | 21.30 | 138,007 | |
| 23.40 | -0.10 | -0.4% | 23.55 | 23.85 | 23.30 | 70,486 | |
| 23.50 | +0.35 | +1.5% | 23.30 | 24.00 | 22.90 | 127,653 | |
| 23.15 | 0.00 | 0.0% | 23.25 | 23.45 | 23.15 | 29,387 | |
| 23.15 | +0.05 | +0.2% | 23.05 | 23.70 | 23.05 | 50,021 | |
| 23.10 | -0.10 | -0.4% | 23.20 | 23.55 | 23.00 | 71,460 | |
| 23.20 | +0.15 | +0.7% | 23.05 | 23.60 | 23.00 | 57,746 | |
| 23.05 | -0.20 | -0.9% | 23.15 | 23.75 | 23.00 | 72,271 | |
| 23.25 | +0.20 | +0.9% | 22.80 | 23.35 | 22.80 | 72,062 | |
| 23.05 | +0.15 | +0.7% | 22.95 | 23.20 | 22.80 | 36,537 | |
| 22.90 | 0.00 | 0.0% | 22.85 | 23.25 | 22.85 | 45,087 | |
| 22.90 | +0.40 | +1.8% | 22.55 | 23.15 | 22.45 | 58,310 | |
| 22.50 | -0.45 | -2.0% | 22.95 | 22.95 | 22.50 | 97,493 | |
| 22.95 | +0.45 | +2.0% | 22.45 | 23.10 | 22.45 | 39,511 | |
| 22.50 | -0.20 | -0.9% | 22.85 | 22.95 | 22.40 | 43,713 | |
| 22.70 | +0.45 | +2.0% | 22.25 | 23.15 | 22.25 | 73,308 | |
| 22.25 | +1.45 | +7.0% | 21.15 | 22.25 | 21.05 | 132,635 | |
| 20.80 | -1.40 | -6.3% | 22.00 | 22.00 | 20.80 | 140,629 | |
| 22.20 | 0.00 | 0.0% | 22.15 | 22.85 | 21.80 | 79,580 | |
| 22.20 | +0.30 | +1.4% | 22.15 | 22.45 | 22.00 | 30,610 | |
| 21.90 | -0.45 | -2.0% | 22.20 | 22.45 | 21.90 | 51,766 | |
| 22.35 | -0.05 | -0.2% | 22.40 | 22.95 | 22.00 | 58,186 | |
| 22.40 | -0.15 | -0.7% | 22.45 | 22.70 | 21.70 | 114,060 | |
| 22.55 | -0.05 | -0.2% | 22.75 | 22.85 | 22.40 | 41,215 | |
| 22.60 | +0.25 | +1.1% | 22.55 | 22.70 | 22.10 | 64,422 | |
| 22.35 | -0.35 | -1.5% | 22.75 | 22.75 | 22.25 | 57,054 | |
| 22.70 | -0.20 | -0.9% | 22.75 | 23.00 | 22.45 | 79,179 | |
| 22.90 | -0.05 | -0.2% | 23.00 | 23.45 | 22.70 | 65,502 | |
| 22.95 | -0.75 | -3.2% | 23.85 | 24.00 | 22.70 | 141,751 | |
| 23.70 | -0.05 | -0.2% | 23.60 | 23.95 | 23.30 | 84,982 | |
| 23.75 | -0.55 | -2.3% | 24.20 | 24.25 | 23.40 | 63,851 | |
| 24.30 | +0.65 | +2.7% | 23.90 | 24.30 | 23.55 | 120,228 | |
| 23.65 | -0.85 | -3.5% | 24.35 | 24.65 | 23.50 | 110,119 | |
| 24.50 | +1.45 | +6.3% | 23.20 | 24.65 | 23.00 | 100,639 | |
| 23.05 | +0.30 | +1.3% | 23.05 | 23.35 | 22.65 | 70,473 | |
| 22.75 | -0.75 | -3.2% | 23.50 | 23.65 | 22.30 | 89,351 | |
| 23.50 | +0.90 | +4.0% | 22.30 | 24.00 | 22.30 | 145,615 | |
| 22.60 | -0.90 | -3.8% | 22.05 | 23.65 | 21.00 | 336,958 | |
| 23.50 | -0.80 | -3.3% | 24.35 | 24.35 | 23.35 | 96,708 | |
| 24.30 | 0.00 | 0.0% | 24.50 | 24.60 | 24.05 | 73,151 | |
| 24.30 | +0.10 | +0.4% | 24.25 | 25.00 | 23.85 | 62,054 | |
| 24.20 | +1.20 | +5.2% | 23.10 | 24.20 | 22.55 | 127,872 | |
| 23.00 | -0.95 | -4.0% | 24.05 | 24.55 | 22.80 | 127,350 | |
| 23.95 | +0.50 | +2.1% | 23.60 | 24.10 | 22.95 | 67,338 | |
| 23.45 | -1.10 | -4.5% | 25.20 | 25.20 | 23.45 | 53,959 | |
| 24.55 | -0.35 | -1.4% | 25.10 | 25.20 | 24.40 | 56,443 |
Splits
6 splits since 2012 · OMXSTO:BINV · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-25 | Consolidation | |
| 57-for-56 | Split | |
| 27-for-25 | Split | |
| 1.107-for-1 | Split | |
| 1.0621-for-1 | Split | |
| 1.007-for-1 | Split |
- Ticker
- Lang & Schwarz:A2QJRW
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Oct 28, 2026
BioInvent International resolves on a rights issue of approximately SEK 430 million subject to approval by an extraordinary general meeting and earlier publication of interim report January - September 2026
Latest earnings call · Feb 26, 2026
BioInvent International (Stockholm:BINV) Q4 2025 Earnings Call
Replay and transcript
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 49 slides
Calls
Replays
BioInvent International (Stockholm:BINV) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 8:00 AM ET
Watch TranscriptBioInvent International (Stockholm:BINV) Q3 2025 Earnings Call
Wed, Oct 29, 2025 · 9:00 AM ET
Watch Transcript
Latest news
BioInvent International resolves on a rights issue of approximately SEK 430 million subject to approval by an extraordinary general meeting and earlier publication of interim report January - September 2026
Oct 28, 2026
Closed 5.71 (-72.4%) on Oct 29, 2026
BioInvent International to present BI-1808 data in platinum-resistant recurrent ovarian cancer at ESMO 2026
Oct 18, 2026
Closed 21.60 (-7.7%) on Oct 19, 2026
BioInvent to Host a KOL Event in Stockholm on June 11, 2026, to Discuss Updated BI-1206 & BI-1808 Data in Hematology
Jun 1, 2026
Closed 31.10 (-6.0%) on Jun 1, 2026
BioInvent to Present Clinical Data on FcγRIIB Antibody BI-1206 Triplet Combination Therapy with rituximab and Calquence(R) in Relapsed/Refractory NHL at EHA 2026
May 12, 2026
Closed 21.25 (-11.1%) on May 12, 2026
BioInvent International AB: Interim Report January - March 2026
Apr 29, 2026
Closed 22.40 (+3.9%) on Apr 29, 2026
BioInvent International AB Publishes Annual Report 2025
Mar 31, 2026
Closed 22.25 (+2.3%) on Mar 31, 2026
BioInvent Achieves Phase 3 Milestone for HMI-115 in Endometriosis
Mar 26, 2026
Closed 22.60 (-3.8%) on Mar 26, 2026
Notice to Annual General Meeting in BioInvent International AB
Mar 24, 2026
Closed 22.15 (-0.4%) on Mar 24, 2026
BioInvent International AB: Year-End Report January 1 - December 31, 2025
Feb 26, 2026
Closed 23.30 (-11.4%) on Feb 26, 2026
Invitation to Presentation of BioInvent's Year-End Report 2025
Feb 26, 2026
Closed 23.30 (-11.4%) on Feb 26, 2026
Financings
Rights offering of new shares with preferential rights
Oct 28, 2026 · US$43.28M
Announced: about SEK 430M · DNB Carnegie Investment Bank AB (publ)
Dealers: DNB Carnegie Investment Bank AB (publ) (lead)
Buyers: Redmile (Subscription commitment; together with other existing shareholders approximately SEK 80 million); Van Herk (Subscription commitment; together with other existing shareholders approximately SEK 80 million); Forbion (Subscription commitment; together with other existing shareholders approximately SEK 80 million); HealthInvest (Subscription commitment; together with other existing shareholders approximately SEK 80 million); DNB Bank ASA (Guarantee undertakings, with others, up to approximately SEK 270 million); Schonfeld Global Master Fund L.P. (Guarantee undertakings, with others, up to approximately SEK 270 million); Anavio Capital Partners LLP (Guarantee undertakings, with others, up to approximately SEK 270 million)
Insiders: Shareholding board members and management intend to subscribe approximately SEK 0.6 million in total, including pro rata from CEO Martin Welschof and Chairman Leonard Kruimer
Use of proceeds: Strengthen financial position and fund clinical development of priority programs, principally BI-1808 and BI-1206 in solid tumors
Decks
Investor Presentation (October 2026)
Investor deck · 49 slides · October 2026
Investor Presentation (October 2026)
Investor deck · 46 slides · October 2026
Investor Presentation (September 2026)
Investor deck · 47 slides · September 2026
Investor Presentation (May 2026)
Investor deck · 43 slides · May 27, 2026
BioInvent International AB on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 14 in the last 12 months · 30 in all · newest Oct 28, 2026 · oldest 2025
- Calls
- 2 calls with a replay · 2 with a transcript · latest Feb 26, 2026
- Decks
- 23 decks · latest October 2026
Where BioInvent International AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:BINV · Home listing | Stockholm | Sweden | SEK |
| Aquis:BINVS | Aquis | United Kingdom | SEK |
| Stuttgart:BIX0 | Stuttgart | Germany | EUR |
| LS Exchange:A2QJRW | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2QJRW · This page | Lang & Schwarz | Germany | EUR |
| gettex:BIX0 | gettex | Germany | EUR |
| Frankfurt:BIX0 | Frankfurt | Germany | EUR |
| Dusseldorf:BIX0 | Dusseldorf | Germany | EUR |
| LSIN:0H22 | LSIN | United Kingdom | SEK |
| Munich:BIX0 | Munich | Germany | EUR |
| OTC:BOVNF | OTC | United States | USD |
| Aquis:BINVS | Aquis | United Kingdom | SEK |
| Turquoise:BINVS | Turquoise | United Kingdom | SEK |
Log in to ask 6ix AI your own questions about BioInvent International AB.